Who are epinephrine perfusion's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Normal saline with epinephrine, High-dose epinephrine, IM epinephrine 1:1000, Epinephrin 0.01, Ephedrine, bolus, Normal saline and epinephrine.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/epinephrine-perfusion.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

epinephrine perfusion — Competitive Intelligence Brief

epinephrine perfusion (epinephrine perfusion) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Sympathomimetic amine / Catecholamine. Area: Cardiovascular / Critical Care.

marketed Sympathomimetic amine / Catecholamine Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors Cardiovascular / Critical Care Small molecule Live · refreshed every 30 min

Target snapshot

epinephrine perfusion (epinephrine perfusion) — Central Hospital, Nancy, France. Epinephrine (adrenaline) acts as a sympathomimetic agent that binds to alpha and beta adrenergic receptors to increase heart rate, blood pressure, and cardiac output.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
epinephrine perfusion TARGET	epinephrine perfusion	Central Hospital, Nancy, France	marketed	Sympathomimetic amine / Catecholamine	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Normal saline with epinephrine	Normal saline with epinephrine	West Penn Allegheny Health System	marketed	Sympathomimetic amine / Vasopressor	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
High-dose epinephrine	High-dose epinephrine	Icahn School of Medicine at Mount Sinai	marketed	Catecholamine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
IM epinephrine 1:1000	IM epinephrine 1:1000	University of Louisville	marketed	Catecholamine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Epinephrin 0.01	Epinephrin 0.01	Kasr El Aini Hospital	marketed	Catecholamine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Ephedrine, bolus	Ephedrine, bolus	University of Parma	marketed	Sympathomimetic amine; adrenergic agonist	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors
Normal saline and epinephrine	Normal saline and epinephrine	Le Bonheur Children's Hospital	marketed	Sympathomimetic amine and crystalloid fluid	Alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Sympathomimetic amine / Catecholamine class)

Central Hospital, Nancy, France · 1 drug in this class
Children's Hospital of Eastern Ontario · 1 drug in this class
Icahn School of Medicine at Mount Sinai · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). epinephrine perfusion — Competitive Intelligence Brief. https://druglandscape.com/ci/epinephrine-perfusion. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab